Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Treasury Shares (2017 - 2025)

Marimed (MRMD) has disclosed Treasury Shares for 2 consecutive years, with $545000.0 as the latest value for Q2 2018.

  • Quarterly Treasury Shares changed N/A to $545000.0 in Q2 2018 from the year-ago period, while the trailing twelve-month figure was $545000.0 through Jun 2018, changed N/A year-over-year, with the annual reading at $45000.0 for FY2017, N/A changed from the prior year.
  • Treasury Shares for Q4 2025 was $9.9 million at Marimed, up from $8.5 million in the prior quarter.
  • The five-year high for Treasury Shares was $545000.0 in Q2 2018, with the low at -$45000.0 in Q3 2017.
  • Average Treasury Shares over 5 years is $5.6 million, with a median of $5.7 million recorded in 2024.
  • The sharpest move saw Treasury Shares plummeted 80.33% in 2021, then surged 1904.63% in 2022.
  • Over 2 years, Treasury Shares stood at $45000.0 in 2017, then surged by 1111.11% to $545000.0 in 2018.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $9.9 million, $8.5 million, and $10.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.